MMRGlobal Retains B. Riley & Co. as Exclusive Financial Advisor

LOS ANGELES, CA--(Marketwire - May 2, 2012) - MMRGlobal, Inc. (OTCBB: MMRF) ("MMR") today announced that it has retained B. Riley & Co., LLC ("B. Riley") www.brileyco.com, a leading independent investment bank, to serve as financial advisors to the Company in connection with a sale and/or merger involving the Company's Personal Health Record ("PHR") and other Health IT products and services and related assets including patents and intellectual property. Additionally, B. Riley will explore opportunities for the sale of the Company's biotech-related assets which include patents, patient samples, anti-CD20 antibodies and other IP. B. Riley & Co., headquartered in Los Angeles with offices in San Francisco, New York and Newport Beach, provides a full array of corporate finance, research, sales and trading services.

Health IT has shown to be a strong industry sector resistant to overall market volatility and beginning to see robust activity in mergers and acquisitions. B. Riley will help guide the Company as interest in healthcare information technology continues to build with government fueling support through the HITECH Act's financial subsidies of electronic medical records adoption by physicians and other healthcare providers. HITECH was part of the American Recovery and Reinvestment Act (ARRA) and, with the government a driving force in modernizing the U.S. healthcare system through computerized medical records and this being a largely bipartisan push originally initiated under President George W. Bush, MMRGlobal is in a space that is experiencing greater growth, maturity and diversity by the year. MMRGlobal's flagship Web-based products, the MyMedicalRecords Personal Health Record and the MMRPro electronic document management and imaging system for healthcare professionals, offer solutions based on proprietary patented technologies that enable both healthcare providers and consumers to securely manage, archive, retrieve and share copies of medical records and other important documents anytime from anywhere using an Internet-connected device.

MMRGlobal will also present at the 13^th Annual B. Riley & Co. Investor Conference scheduled for May 21-23, 2012 at the Loews Santa Monica Beach Hotel. More than 1,000 professionals are invited to attend the invitation-only conference, including senior company executives and institutional, private equity and venture capital investors. The Company will present on Monday, May 21^st as part of "Discovery Day," a conference session dedicated to prospecting for emerging growth opportunities.

On the evening of May 22^nd, conference attendees will join legendary world boxing champion Sugar Ray Leonard, who is also a member of MMRGlobal's Board of Advisors, for the 3rd Annual "Big Fighters, Big Cause" Charity Fight Night. The event benefits the Sugar Ray Leonard Foundation and its support of the Juvenile Diabetes Research Foundation as well as the Wounded Warrior Project. Last year, Bob Lorsch, MMRGlobal's Chairman and CEO, with his wife Kira Lorsch, chaired The Thalians annual charity gala, which raised over $1 million for America's Wounded Warriors in connection with UCLA Health System's Operation Mend and its program to heal U.S. servicemen and women injured in Iraq and Afghanistan. At the event, MMR also launched its "MyBlueButton.com" program for Veterans.

About MMRGlobal, Inc.

MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video tutorials of the Company's products and services at www.mmrtheater.com.

About B. Riley & Co.

B. Riley & Co. is a leading independent investment bank which provides a full array of corporate finance, research, sales, trading and otcqx dad services to corporate, institutional and high net worth individual clients. Investment banking services include merger and acquisitions advisory to public and private middle market companies, initial and secondary public offerings and institutional private placements. Its Corporate Governance Advisory Services Group is engaged by both companies and investors to help maximize value for shareholders. The firm is recognized for its distinguished Equity Research. Founded in 1997, B. Riley is headquartered in Los Angeles and maintains offices in Newport Beach, San Francisco, and New York. It is a member of FINRA and SIPC. For more information, please visit http://www.brileyco.com

Forward-Looking Statements

Any statements contained in this press release that refer to future events or other non-historical matters are forward-looking statements, and some can be identified by the use of words (and their derivations) such as "need," "possibility," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," "help" and "continue," or the negative of such terms and other comparable terminology. MMRGlobal, Inc. disclaims any intent or obligation to revise or update any forward-looking statements. These forward-looking statements are based on MMRGlobal, Inc.'s reasonable expectations as of the date of this press release and are subject to risks and uncertainties that could cause actual results to differ materially from current expectations. The information discussed in this release is subject to various risks and uncertainties related but not limited to changes in MMRGlobal, Inc.'s business prospects, its results of operations or financial condition, current uncertainty and instability in financial and lending markets including global economic uncertainties, the risk the Company's products are not adopted or viewed favorably by the healthcare community, the ability to establish and maintain strategic relationships, competitive product offerings and promotions, regulation and changes in healthcare initiatives, maintaining, developing and defending our intellectual property rights, licensing and exploitation of our patent portfolio both in the U.S. and internationally; and such other risks and uncertainties as detailed from time to time in MMRGlobal, Inc.'s public filings with the U.S. Securities and Exchange Commission.